BiVictriX Therapeutics plc announced that Non-Executive Director, Iain Ross, is stepping down from the board with immediate effect to pursue other interests. A Nomination Committee, consisting of Non-Executive Directors and chaired by Dr. Michael Kauffman, will initiate a search for Iain's replacement with appropriate skills to help move the Company forward, in anticipation of its first clinical trials in patients with Acute Myeloid Leukaemia.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13 GBX | 0.00% |
|
+4.00% | +23.81% |
Jun. 21 | BiVictriX Therapeutics Plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jun. 13 | EARNINGS AND TRADING: Dialight trades in line; Petards swings to loss | AN |
![Consensus](/images/consensus_flch.gif)
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.81% | 13.71M | |
+16.71% | 44.48B | |
+43.79% | 40.57B | |
-7.92% | 38.82B | |
+33.09% | 32.22B | |
-7.10% | 27.84B | |
+14.46% | 26.79B | |
+46.73% | 14.31B | |
+34.07% | 12.7B | |
-7.61% | 11.23B |
- Stock Market
- Equities
- BVX Stock
- News BiVictriX Therapeutics plc
- Bivictrix Therapeutics plc Announces Resignation of Iain Ross from the Board